Phase I/IIa Study of BR1733 in Subjects With Advanced Cancers

Clinical trial NCT05749549 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05749549
Sponsor: Shanghai Blueray Biopharma Co., Ltd.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Cancer Follicular Lymphoma Peripheral T Cell Lymphoma Diffuse Large B Cell Lymphoma

Start date: 2023-04-19
Primary completion: 2025-05-01
Enrollment: 191

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.